Company Filing History:
Years Active: 2002-2022
Title: Hiroaki Harada: Innovator in Communication and Therapeutic Screening
Introduction
Hiroaki Harada is a notable inventor based in Tokyo, Japan. He has made significant contributions to the fields of communication technology and therapeutic agent screening. With a total of 4 patents, his work has had a considerable impact on both industries.
Latest Patents
Hiroaki Harada's latest patents include a method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5. This innovative method provides a way to identify agents for the prevention or treatment of these diseases, focusing on changes in the expression and function of the MEX3B gene and protein. Additionally, he has developed a communication device that transmits voice and facsimile signals over the same channel. This device features an echo canceler and a jitter buffer, which enhances communication quality by managing packet delays effectively.
Career Highlights
Throughout his career, Hiroaki Harada has worked with prominent companies such as Oki Electric Industry Co., Ltd. and Tak-Circulator Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in technology and healthcare.
Collaborations
Hiroaki has collaborated with notable coworkers, including Tomio Sugimoto and Masumi Itaya. Their combined expertise has fostered an environment of innovation and creativity, leading to the development of impactful technologies.
Conclusion
Hiroaki Harada's contributions to communication technology and therapeutic screening exemplify the spirit of innovation. His patents and collaborations reflect a commitment to advancing technology for the betterment of society.